Study identifier:NIS-RTR-XXX-2012/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Validation of questionnaire and assessment of patient satisfaction for budesonide/formoterol fix combination DPI in COPD
Chronic obstructive pulmonary disease (COPD)
-
No
-
All
446
Observational
40 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Oct 2012 by AstraZeneca
AstraZeneca
-
The aim of this study is to describe patient preferences on budesonide/formoterol fix dose combination for the treatment of their COPD, and to find those factors more strongly associated to a better attitude to medication.
Validation of questionnaire and assessment of patient satisfaction for budesonide/formoterol fix combination DPI in COPD
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.